Logo IASO BIOTECH
Member

IASO BIOTECH

Activities

IASO is developing a microalgae-based industrial platform for the bioproduction of recombinant proteins. It includes a technological ‘ensemble’ consisting of our own cell lines, specific and optimized upstream and downstream processes, all respecting the good manufacturing practices of the pharmaceutical industry. After validating our proof of concept with a few target molecules, our ambition is to become the first CDMO using µA for the production of biopharmaceutical proteins.Easy to grow, edible, free of animal pathogens, able to comply with regulations, µA are produced by photosynthesis under artificial light or with a source of carbon in fermenters. We explore their potential as vectors for different modes of drug delivery. For this game-changing project, the team gathers expertise in 4 engineering: Genetics & biology – Microalgae process – Pharmacology – Industrial development.
Back to the directory